Relapsed/Refractory B-Cell LymphomaPhase 1/2NCT03223610Papers
ViPOR Combination
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies
What the film says
This trial is for adults with Hodgkin lymphoma or other CD30 positive blood cancers that have come back or not responded to treatment.
The idea: collect the patient's own T cells, activate them, and coat them with a bispecific antibody that grabs CD30 on cancer cells and CD3 on the T cell. The armed T cells are then given back. This is the first time this treatment is tested in people.
The study looks at safety, feasibility, and how well it works.
This phase 1 study plans 42 patients. At the Medical College of Wisconsin in Milwaukee, Guru Subramanian Guru Murthy leads it.
Public record; not medical advice.
Sources behind this film
Adults; relapsed/refractory CD30+ cancers incl. Hodgkin; Own T cells activated, armed with CD30xCD3 bispecific; First-in-human; Safety, feasibility, efficacy (+1 more lines)
The drug
anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells
Hematopoietic agent that helps form white blood cells.
Non-randomized, single arm, dose escalating, Phase I study evaluating the feasibility and safety of a novel anti-CD30 biAb-AATC product for adult patients with relapsed/refractory CD30+ cancer. Following T-cell collection patients are recommended to receive a bridging chemotherapy for 21 days while product is being generated and quality control assessed.
The study
This first-in-human trial will assess the safety, feasibility, and efficacy of an immunotherapy with a novel CD30 antibody conjugated to a CD3 antibody that is preloaded onto a patient's own T-cells, generating a CD30 bispecific antibody-armed, anti-CD3-activated, autologous T-cells (CD30 biAb-AATC).
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.